Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death.

α-Casein (90-95) is a peptide fragment of α-Casein.

N-Sulfo-glucosamine sodium salt is possible to effect reaction at arthritis.